Results 1 to 10 of about 59,570 (191)
Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
The Egyptian Journal of Bronchology, 2019 Background Pleural effusion can arise as a result of more than 50 recognized causes and the differentiation between benign and malignant origin of the fluid is still a diagnostic challenge.
Omar M. Mohammed +5 more
doaj +2 more sources
Clinics in Chest Medicine, 2021 Malignant pleural effusions have a significant burden on patients and the health care system. Diagnosis is typically via thoracentesis, although other times more invasive procedures are required. Management centers around relief of dyspnea and patient quality of life and can be done via serial thoracentesis, indwelling pleural catheter, or pleurodesis.
Duilio Divisi, Roberto Crisci
openalex +3 more sources
Malignant Pleural Effusion: Diagnosis and Treatment—Up-to-Date Perspective [PDF]
Current OncologyMalignant pleural effusion is the presence of malignant cells within the pleural fluid, representing the second most common cause of pleural exudate. Although diagnostic methods and management techniques for malignant pleural effusion have dramatically ...
Riccardo Orlandi +10 more
doaj +2 more sources
The significance of Fas, tumor necrosis factor-related apoptosis-inducing ligand and fibrinolytic factors in the assessment of malignant pleural effusion [PDF]
Archives of Biological Sciences, 2022 Few studies have examined the usefulness of soluble apoptotic markers for the screening of pleural effusion. This study aimed to investigate the significance of Fas, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and fibrinolytic factors
Choi Jong Weon +2 more
doaj +1 more source
BMC Pulmonary Medicine, 2023 Aim To investigate the diagnostic value of combined detection of SHOX2 and RASSF1A gene methylation with carcinoembryonic antigen (CEA) level in diagnosing malignant pleural effusion.
Shaosen Chen +4 more
doaj +1 more source
Malignant pleural effusion [PDF]
QJM, 2013 Malignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid. Approximately 40 000 people per year in the UK are affected by MPE and it is associated with significant morbidity and an overall poor prognosis. Management should be prompt and care plans should be individualized and involve a multidisciplinary team of ...
Egan, A. M. +3 more
openaire +3 more sources
Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
Thoracic Cancer, 2020 Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male.
Eiji Takeuchi +6 more
doaj +1 more source
Life, 2023 Malignant pleural effusion is associated with a poor prognosis and, while risk stratification models exist, prior studies have not evaluated pleural fluid resolution and its association with survival.
Christina R. MacRosty +5 more
doaj +1 more source
Egyptian Journal of Chest Disease and Tuberculosis, 2014 Pleural effusion is relatively common clinical condition that requires differential diagnosis. It is defined as collection of fluid in pleural space. Pleural effusion is often diagnostic dilemma for the physician.
Wafaa S. El-Shimy +4 more
doaj +1 more source
New biomarkers for the diagnosis of pleural effusion
The Egyptian Journal of Bronchology, 2022 Background Persistent undiagnosed effusion is present in approximately 15% of all causes of exudative effusion. Pleural effusion caused by immunoglobulin G4 (IgG4) is a new type of pleural effusion.
Raafat T. El-Sokkary +3 more
doaj +1 more source